TABLE 3-2.
Summary of Treatment Regimens for Helicobacter mustelae Gastritis, Inflammatory Bowel Disease, Proliferative Bowel Disease, and Eosinophilic Gastroenteritis
Disease | Drug | Dosage | |
---|---|---|---|
Helicobacter mustelae gastritis | Amoxicillin | 10mg/kg q12h PO | |
Original triple therapy* | Metronidazole | 20mg/kg q12h PO | |
Bismuth subsalicylate | 17mg/kg (1 mL/kg) q12h PO | ||
Alternative therapy* | Clarithromycin | 12.5mg/kg q8h PO36 | |
Ranitidine bismuth citrate | 24mg/kg q8h PO36 | ||
or | |||
Clarithromycin | 50mg/kg q24h PO1 | ||
Omeprazole | 4mg/kg q24h PO1 | ||
Metronidazole | 75mg/kg q24h PO1 | ||
Inflammatory bowel disease | Azathioprine | 0.9mg/kg PO q24–72h | |
Prednisone | 1mg/kg PO q24h | ||
Sucralfate | 100mg/kg PO q6h | ||
Hypoallergenic diet | |||
Proliferative bowel disease | Chloramphenicol | 50mg/kg q12h PO, IM, SC | |
Eosinophilic gastroenteritis | Prednisone | 1.25–2.5mg/kg q24h PO | |
Ivermectin | 0.4mg/kg SC, PO once; repeat in 14d |
IM, Intramuscular; PO, per os; SC, subcutaneous.
Chloramphenicol, ranitidine bismuth citrate, azathioprine, and metronidazole can be prepared as suspensions by compounding pharmacists.
Treat for a minimum of 14 days.